Alnylam Pharmaceuticals
ALNY
ALNY
164 hedge funds and large institutions have $3.27B invested in Alnylam Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 55 increasing their positions, 52 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
18% more funds holding
Funds holding: 139 → 164 (+25)
6% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 52
Holders
164
Holding in Top 10
4
Calls
$27M
Puts
$22.2M
Top Buyers
| 1 | +$132M | |
| 2 | +$123M | |
| 3 | +$113M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$39.9M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$27.1M |
Top Sellers
| 1 | -$58.5M | |
| 2 | -$37.3M | |
| 3 | -$35.6M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$31.2M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$31M |